July/August 2013

The ATS 2013 conference focused on pulmonary care, critical care, sleep medicine, and more.

We examined the prevalence of use and cost impact of DPP-4 inhibitors and GLP-1 receptor agonists in people with diabetes.

A tool for organizing patient concerns and comments to ensure that the FDA captures the comprehensive information it needs to integrate patient perspectives throughout the agency's review process.

Using the SEER-Medicare database, we found negative association between Medicare claim processors“related physician's chemotherapy reimbursement and their prescription of granulocyte colony-stimulating factor for non-Hodgkin lymphoma patients.

With increasing regulatory oversight for sterile compounding and a limited ability to assure the quality of compounded sterile products obtained from external sources, many hospital pharmacies are moving to insource these products.

Physicians should work with retail pharmacies to find cost-effective medication strategies for their patients.